Trial Profile
Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Immunosuppressants
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Roche
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2012 New trial record